Nusinersen in spinal muscular atrophy: Respiratory outcomes at tertiary care centers
Objectives: The objective of the study wasto describe the effect of nusinersen therapy and its 1st-year associated outcomes, weaning of ventilator support, and length of stay in pediatric intensive care among ventilator-dependent spinal muscular atrophy (SMA) patients. Methods: This is a multicenter...
Main Authors: | Fahad Alsohime, Mohamad-Hani Temsah, Muneera Al-Jelaify, Hind Ali Bafaqih, Kamal El Masri, Ahmed Abusibah, Ayman Al-Eyadhy, Gamal Hasan, Ali Alhaboob, Majed Alabdulhafid, Mohammed Abdulrahman Almazyad, Abdulaziz Alghamdi, Fahad A Bashiri |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Nature and Science of Medicine |
Subjects: | |
Online Access: | http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2020;volume=3;issue=3;spage=165;epage=169;aulast=Alsohime |
Similar Items
-
2020 Update to Spinal Muscular Atrophy Management in Saudi Arabia
by: Fahad A. Bashiri, et al.
Published: (2021-05-01) -
Proxy-Reported Quality of Life and Access to Nusinersen Among Patients with Spinal Muscular Atrophy in Saudi Arabia
by: AlRuthia Y, et al.
Published: (2021-04-01) -
Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?
by: Caterina Agosto, et al.
Published: (2021-09-01) -
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
by: Maren Freigang, et al.
Published: (2021-07-01) -
Cost effectiveness of nusinersen for patients with infantile-onset spinal muscular atrophy in US
by: Praveen Thokala, et al.
Published: (2020-10-01)